(Q33745173)

29 July 2017

1 reference

title

Monoclonal antibody drug conjugates in the treatment of cancer (English)

1 reference

29 July 2017

1 reference

Trail PA

1

1 reference

PubMed ID

10508711

29 July 2017

Bianchi AB

series ordinal

2

1 reference

29 July 2017

1 October 1999

1 reference

Current Opinion in Immunology

29 July 2017

1 reference

29 July 2017

11

1 reference

29 July 2017

584-588

1 reference

29 July 2017

5

1 reference

Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2900012-6

7 January 2021

Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2900012-6

7 January 2021

Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2900012-6

7 January 2021

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2900012-6

7 January 2021

Delivery of molecular and cellular medicine to solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2900012-6

7 January 2021

Monoclonal antibody conjugates of doxorubicin prepared with branched linkers: A novel method for increasing the potency of doxorubicin immunoconjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2900012-6

7 January 2021

Anti-HER2 immunoliposomes for targeted therapy of human tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2900012-6

7 January 2021

Sterically stabilized anti-idiotype immunoliposomes improve the therapeutic efficacy of doxorubicin in a murine B-cell lymphoma model

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2900012-6

7 January 2021

Tumor Infarction in Mice by Antibody-Directed Targeting of Tissue Factor to Tumor Vasculature

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2900012-6

7 January 2021

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2900012-6

7 January 2021

Chemotherapy targeted to tumor vasculature.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2900012-6

7 January 2021

The enediyne antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2900012-6

7 January 2021

Antitumour activity of an immunoconjugate composed of anti-human astrocytoma monoclonal antibody and neocarzinostatin

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2900012-6

7 January 2021

Targeted chemotherapy in mice with peritoneally disseminated gastric cancer using monoclonal antibody-drug conjugate

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2900012-6

7 January 2021

The effect of intravenous and intra-tumoural chemotherapy using a monoclonal antibody-drug conjugate in a xenograft model of pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2900012-6

7 January 2021

Monoclonal antibody 138H11 against gamma-glutamyltransferase provides a possible tool for targeting calicheamicin theta to renal cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2900012-6

7 January 2021

Calicheamicin derivatives conjugated to monoclonal antibodies: determination of loading values and distributions by infrared and UV matrix-assisted laser desorption/ionization mass spectrometry and electrospray ionization mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2900012-6

7 January 2021

(6-Maleimidocaproyl)hydrazone of doxorubicin--a new derivative for the preparation of immunoconjugates of doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2900012-6

7 January 2021

Randomized phase II study of BR96-doxorubicin conjugate in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2900012-6

7 January 2021

Immunoconjugates and immunotoxins for therapy of carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2900012-6

7 January 2021

HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. II. Processing in epithelial ovarian carcinoma cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2900012-6

7 January 2021

Antitumoral activity of liposomes and immunoliposomes containing 5-fluorouridine prodrugs

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2900012-6

7 January 2021

Pharmacokinetics of stealth versus conventional liposomes: effect of dose

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2900012-6

7 January 2021

Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2900012-6

7 January 2021

Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2900012-6

7 January 2021

New perspectives in clinical oncology from angiogenesis research

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2900012-6

7 January 2021

Targeting the tumor vasculature: inhibition of tumor growth by a vascular endothelial growth factor-toxin conjugate

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2900012-6

7 January 2021

10.1016/S0952-7915(99)00012-6

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10508711